Lisa Padilla

Lisa Padilla, JD, LLM, NACD.DC, serves as the CEO of ExOcular DX Inc, leading the development of innovative diagnostics for eye diseases using exosome technology. Additionally, Lisa is involved with Innosphere Ventures and volunteers as a business mentor at the University of Colorado Anschutz Medical Campus. Formerly, Lisa was the CEO of Beryl Therapeutics, Inc., focusing on drug development for bone health, and held a board member position at Callen-Lorde Community Health Center. Lisa's extensive legal background includes practicing as a tax attorney and adjunct professor in tax law, alongside an education that includes a Master of Laws in Taxation and Director Certification from the National Association of Corporate Directors.